RecruitingPhase 1NCT06996756

Gene Therapy for Alpha 1- Antitrypsin Deficiency

Studying Alpha-1-antitrypsin deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Weill Medical College of Cornell University
Principal Investigator
Ronald G Crystal, MD
Weill Medical College of Cornell University
Intervention
AAV8hAAT(AVL)(biological)
Enrollment
16 enrolled
Eligibility
18-70 years · All sexes
Timeline
20252032

Study locations (1)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06996756 on ClinicalTrials.gov

Other trials for Alpha-1-antitrypsin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Alpha-1-antitrypsin deficiency

← Back to all trials